Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Galecto (GLTO)
NASDAQ:GLTO
Galecto (GLTO) Stock Price & Analysis
176 Followers
GLTO Stock Chart & Stats
Day’s Range$0.65 - $0.72
52-Week Range― - ―
Previous Close$0.67
Volume107.48K
Average Volume (3M)N/A
Market Cap
$18.28M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Apr 26, 2024EPS Estimate
-$0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Galecto News
Ownership Overview
21.02% Insiders
2.38% Mutual Funds
10.58% Other Institutional Investors
66.01% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
GLTO FAQ
What was Galecto’s price range in the past 12 months?
Currently, no data Available
What is Galecto’s market cap?
Currently, no data Available
When is Galecto’s upcoming earnings report date?
Galecto’s upcoming earnings report date is Apr 26, 2024 which is in 7 days.
How were Galecto’s earnings last quarter?
Galecto released its earnings results on Mar 25, 2024. The company reported -$0.35 earnings per share for the quarter, the consensus estimate of -$0.35 by $0.
Is Galecto overvalued?
According to Wall Street analysts Galecto’s price is currently Overvalued.
Does Galecto pay dividends?
Galecto does not currently pay dividends.
What is Galecto’s EPS estimate?
Galecto’s EPS estimate is -$0.41.
How many shares outstanding does Galecto have?
Currently, no data Available
What happened to Galecto’s price movement after its last earnings report?
Galecto reported an EPS of -$0.35 in its last earnings report, expectations of -$0.35. Following the earnings report the stock price went down -5.128%.
Which hedge fund is a major shareholder of Galecto?
Among the largest hedge funds holding Galecto’s share is Maverick Capital ltd. It holds Galecto’s shares valued at N/A.
---
Galecto Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.43%
12-Months-Change
Fundamentals
Return on Equity
-81.52%
Trailing 12-Months
Asset Growth
-47.77%
Trailing 12-Months
Company Description
Galecto
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis & impact a broad range of fibrotic & related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.
---
GLTO Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering GLTO
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
-20.97%
reiterated a buy rating 5 months ago
Copying Jay Olson's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -20.97% per trade.
---